Hibsago (bepirovirsen) approved in the US for the treatment of chronic hepatitis B (CHB) Approval based on phase III data ...
GSK Presents First Global Data for Ris-Rez in Extensive-Stage Small Cell Lung Cancer 61% overall response rate in phase Ib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results